+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Capillary Blood Collection Devices Market Analysis Report By Material (Plastic, Glass, Stainless Steel), By Product, By Application (Whole Blood, Plasma Tests), By End Use, And Segment Forecasts, 2018 - 2025

  • ID: 4751768
  • Report
  • 125 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cardinal Health
  • KABE LABORTECHNIK GmbH
  • Nipro Europe NV
  • Owen Mumford Ltd.
  • SARSTEDT AG & Co. KG
  • MORE
The global capillary blood collection devices market size is expected to reach USD 1.75 billion by 2025, at a CAGR of 5.4% during the forecast period. Increasing incidence of chronic, infectious and autoimmune diseases are some of the major factors propelling market growth owing to rising number of blood tests globally. Capillary blood draw technique has been most widely used for glucose and hemoglobin testing in clinics and hospitals. Ease of usage and minimally invasive nature also makes it ideal for home care diagnosis and testing, thereby boosting the market’s growth potential.The use of this technique in conjugation with PoC diagnostics has become the chosen mode of testing in remote and ambulatory health settings.

Blood gas detection, leukocyte & metabolite count, biomarker, nucleic acid, blood glucose, ferritin, lactate, effect of vitamin K-antagonist, and heavy metal ions analysis is commonly done using these samples. Thus, with rising adoption of rapid PoC diagnostics, usage of these devices is anticipated to increase in the near future.

Chronic diseases are a global healthcare problem with over half of the adult population in the U.S. suffering from chronic diseases, which contribute to over 75% of the total healthcare cost in the nation. Thus, rising number of infectious and chronic diseases creates a huge demand for diagnostic testing, thereby propelling growth of these collection devices.

Capillary blood draw technique is most often used in case of pediatric patients as it is difficult to draw venous and arterial blood from infants. Capillary blood draw is preferred in many ICU settings as patients lose large amount of blood during surgeries. Other blood drawing techniques are more invasive and might result in delays in the healing process or pose a risk of contamination. Ease of usage and effectiveness is another factor facilitating the use of these devices for home care diagnosis and testing, typically in case of diabetics.

Further Key Findings From the Report Suggest:
  • Plastic devices held the largest market share in 2017 owing to their lightweight, cost-effective, and biocompatible nature coupled with extensive usage in medical devices
  • Durability, non-porous nature, and impermeability are boosting the demand for glass devices
  • Plastic and glass based collection devices are anticipated to dominate the market throughout the forecast horizon during the forecast period due to their extensive use in the manufacture of medical devices and other related products.
  • North America will lead the market throughout the forecast period owing to existence of large number of major market players and high incidence of chronic and infectious diseases
  • The Asia Pacific market is expected to rise at the highest CAGR during the same period. High population along with rising incidence of chronic diseases such as cancer and diabetes are the major factors contributing to the growth of the regional market
  • Some of the major players are Becton, Dickinson and Company; NIPRO Europe Corporation; Sarstedt AG & Co; Thermo Fisher Scientific Inc.; Terumo Medical Corporation; B Braun Melsungen AG; Kabe Labortechnik GmbH; Greiner Bio One International GmbH; Cardinal Health; and Owen Mumford Ltd.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cardinal Health
  • KABE LABORTECHNIK GmbH
  • Nipro Europe NV
  • Owen Mumford Ltd.
  • SARSTEDT AG & Co. KG
  • MORE
Chapter 1 Executive Summary


Chapter 2 Research Methodology
2.1 Country-wise Market: Base Estimates
2.2 Global Market: CAGR Calculation
2.3 Region-based Segment Share Calculation
2.4 Research Scope & Assumptions
2.5 List of Data Sources
2.5.1 Data for primary interviews, by sources
2.5.2 Data for primary interviews, by region
2.6 Market Snapshot

Chapter 3 Capillary Blood Collection Market Devices Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Rising availability of Point-of-Care (PoC) diagnostics
3.2.2 Rising prevalence of chronic and infectious diseases
3.2.3 Diabetes incidence, 2017 & 2025
3.2.4 U.S. estimated deaths due to cancer, 2017
3.2.5 Advantages over other forms of blood collection
3.3 Market Restraint Analysis
3.3.1 Disadvantages over other forms of blood collection
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by material
3.4.2 Key opportunities prioritized, by product
3.4.3 Key opportunities prioritized, by application
3.4.4 Key opportunities prioritized, by end use
3.5 Capillary Blood Collection Devices - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.6 Industry Analysis - Porter’s
3.7 Capillary Blood Collection Devices Market: Company Market Position Analysis, 2017

Chapter 4 Capillary Blood Collection Devices Market: Material Estimates & Trend Analysis
4.1 Capillary Blood Collection Devices Market: Material Movement Analysis
4.2 Plastic
4.2.1 Plastic market, 2014 - 2025 (USD Million)
4.3 Glass
4.3.1 Glass market, 2014 - 2025 (USD Million)
4.4 Stainless Steel
4.4.1 Stainless steel market, 2014 - 2025 (USD Million)
4.5 Ceramic
4.5.1 Ceramic market, 2014 - 2025 (USD Million)
4.6 Others
4.6.1 Others market, 2014 - 2025 (USD Million)

Chapter 5 Capillary Blood Collection Devices Market: Product Estimates & Trend Analysis
5.1 Capillary Blood Collection Devices Market: Product Movement Analysis
5.2 Lancets
5.2.1 Lancets market, 2014 - 2025 (USD Million)
5.3 Micro-Container Tubes
5.3.1 Micro-Container tubes market, 2014 - 2025 (USD Million)
5.4 Micro-Hematocrit Tubes
5.4.1 Micro-Haematocrit tubes market, 2014 - 2025 (USD Million)
5.5 Warming Devices
5.5.1 Warming devices market, 2014 - 2025 (USD Million)
5.6 Others
5.6.1 Others market, 2014 - 2025 (USD Million)

Chapter 6 Capillary Blood Collection Devices Market: Application Estimates & Trend Analysis
6.1 Capillary Blood Collection Devices Market: Application Movement Analysis
6.2 Whole Blood Tests
6.2.1 Whole blood tests market, 2014 - 2025 (USD Million)
6.3 Plasma/Serum Protein Test
6.3.1 Plasma/serum protein tests market, 2014 - 2025 (USD Million)
6.4 Comprehensive Metabolite Panel (CMP)
6.4.1 CMP tests market, 2014 - 2025 (USD Million)
6.5 Liver Panel/Liver Profile/Liver Function Tests (LFTs)
6.5.1 LFT tests market, 2014 - 2025 (USD Million)
6.6 Dried Blood Spot Tests
6.6.1 Dried blood spot tests market, 2014 - 2025 (USD Million)

Chapter 7 Capillary Blood Collection Devices Market: End Use Estimates & Trend Analysis
7.1 Capillary Blood Collection Devices Market: End Use Movement Analysis
7.2 Hospitals and Clinics
7.2.1 Hospitals & clinics market, 2014 - 2025 (USD Million)
7.3 Blood Donation Centers
7.3.1 Blood donation centers market, 2014 - 2025 (USD Million)
7.4 Diagnostic Centers
7.4.1 Diagnostic centers market, 2014 - 2025 (USD Million)
7.5 Home Diagnosis
7.5.1 Home diagnosis market, 2014 - 2025 (USD Million)
7.6 Pathology Laboratories
7.6.1 Pathology laboratories market, 2014 - 2025 (USD Million)

Chapter 8 Capillary Blood Collection Devices Market: Regional Estimates & Trend Analysis, by Material, Product, Application, and End Use
8.1 Capillary Blood Collection Devices Market Share, by Region, 2017 & 2025
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 U.K.
8.3.2 Germany
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.6 Middle East & Africa (MEA)
8.6.1 South Africa

Chapter 9 Competitive Landscape
9.1 Company Profiles
9.1.1 SARSTEDT AG & Co. KG
9.1.1.1 Company overview
9.1.1.2 Product benchmarking
9.1.2 Becton, Dickinson and Company (BD)
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Product benchmarking
9.1.3 Thermo Fisher Scientific, Inc.
9.1.3.1 Company overview
9.1.3.2 Financial performance
9.1.3.3 Product benchmarking
9.1.4 Terumo Medical Corp.
9.1.4.1 Company overview
9.1.4.2 Product benchmarking
9.1.4.3 Strategic initiatives
9.1.5 Cardinal Health
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Product benchmarking
9.1.6 Nipro Europe NV
9.1.6.1 Company overview
9.1.6.2 Product benchmarking
9.1.6.3 Strategic initiatives
9.1.7 KABE LABORTECHNIK GmbH
9.1.7.1 Company overview
9.1.7.2 Product benchmarking
9.1.8 B. Braun Melsungen AG
9.1.8.1 Company overview
9.1.8.2 Financial performance
9.1.8.3 Product benchmarking
9.1.9 Owen Mumford Ltd.
9.1.9.1 Company overview
9.1.9.2 Product benchmarking
9.1.10 Greiner Bio One International GmbH
9.1.10.1 Company overview
9.1.10.2 Financial performance
9.1.10.3 Product benchmarking
9.1.10.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • SARSTEDT AG & Co. KG
  • Becton, Dickinson and Company (BD)
  • Thermo Fisher Scientific, Inc.
  • Terumo Medical Corp.
  • Cardinal Health
  • Nipro Europe NV
  • KABE LABORTECHNIK GmbH
  • B. Braun Melsungen AG
  • Owen Mumford Ltd.
  • Greiner Bio One International GmbH
Note: Product cover images may vary from those shown
Adroll
adroll